Similar results in prostate cancer patients were obtained by Saǧlam et al., while the concentration of PSA in patients with BPH and healthy control was higher than in our study (3.17 versus 3.36 ng/mL, resp). The gene discussed is KLK3; the disease is benign prostatic hyperplasia.